erythema/悪性腫瘍

This invention is that of a method of detecting in a human subject the level or extent of the subject's immunity against malignant tumor occurrence or development, by (a) intradermally injecting into the subject an isotonic diagnostic solution (i) of the polysaccharide-like antigenic product

FIELD OF THE INVENTION The invention relates to chemical compounds and pharmaceutical compositions, including novel chemical compounds and pharmaceutical compositions thereof, useful in the treatment of various diseases and disease states. The invention also relates to methods of synthesizing

FIELD OF THE INVENTION The invention relates to chemical compounds and pharmaceutical compositions, including novel chemical compounds and pharmaceutical compositions thereof, useful in the treatment of various diseases and disease states. The invention also relates to methods of synthesizing

It is a well-known fact that ultraviolet radiation, i.e. electromagnetic radiation within the wavelength range of 100-400 nm, may cause biological skin effects and even severe skin diseases. Thus, exposure to ultraviolet radiation may result in erythema, and excessive exposure to ultraviolet

TECHNICAL FIELD The present invention relates to methods of treating subclinical sun damage and of inducing a chemocytotoxic response through application of a chemocytotoxic agent. Specific such agents comprise a fluorinated pyrimidine antimetabolite, for example, 5-fluorouracil. BACKGROUND Since

This application is a national stage application under 35 U.S.C. .sctn. 371 which claims priority of PCT Application No. PCT/CN2015/084492, filed Jul. 20, 2015. FIELD OF THE INVENTION The present invention substantially relates to the technical field of drugs, cosmetics, medical products,

FIELD OF THE INVENTION The present invention relates to a 3-aminocarbazole compound, to a pharmaceutical composition containing the same and to a method for the preparation thereof. More particularly, the present invention relates to a 3-aminocarbazole compound that is useful for treating or

FIELD OF THE INVENTION The current invention relates to personal care compositions having a polymer-bound ultraviolet (UV) absorber. In a first embodiment the polymer-bound UV absorbers comprise at least one unit having the structure: ##STR00002## wherein: (a) Chr-X is the residue of a UV absorber,

FIELD OF THE INVENTION The current invention relates to personal care compositions having a polymer-bound ultraviolet (UV) absorber. In a first embodiment the polymer-bound UV absorbers comprise at least one unit having the structure: ##STR00002## wherein: (a) Chr-X is the residue of a UV absorber,

BACKGROUND OF THE INVENTION 1. Field of the Invention The invention concerns reducing side-effects of certain chemotherapy, and particularly, side-effects manifested topically in areas of the hands and feet. 2. The Related Art Chemotherapy can result in predictable toxicity to organs. An important

FIELD OF THE INVENTION The invention relates to chemical compounds and pharmaceutical compositions, including novel chemical compounds and pharmaceutical compositions thereof, useful in the treatment of various diseases and disease states. The invention also relates to methods of synthesizing